Dr. Martens Past Earnings Performance
Past criteria checks 2/6
Dr. Martens has been growing earnings at an average annual rate of 17.6%, while the Luxury industry saw earnings growing at 16.5% annually. Revenues have been growing at an average rate of 10.9% per year. Dr. Martens's return on equity is 18.8%, and it has net margins of 7.9%.
Key information
17.6%
Earnings growth rate
17.5%
EPS growth rate
| Luxury Industry Growth | 27.6% |
| Revenue growth rate | 10.9% |
| Return on equity | 18.8% |
| Net Margin | 7.9% |
| Next Earnings Update | 28 Nov 2024 |
Recent past performance updates
Recent updates
Benign Growth For Dr. Martens plc (LON:DOCS) Underpins Stock's 30% Plummet
Sep 21
Is There An Opportunity With Dr. Martens plc's (LON:DOCS) 45% Undervaluation?
Aug 20Dr. Martens (LON:DOCS) Has Some Way To Go To Become A Multi-Bagger
Jul 20There May Be Some Bright Spots In Dr. Martens' (LON:DOCS) Earnings
Jun 19Dr. Martens plc's (LON:DOCS) Price Is Right But Growth Is Lacking After Shares Rocket 27%
May 21The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested
Mar 27Dr. Martens (LON:DOCS) Has A Somewhat Strained Balance Sheet
Mar 06Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 57% Above Its Share Price
Feb 08Dr. Martens plc's (LON:DOCS) Business And Shares Still Trailing The Market
Jan 21Dr. Martens' (LON:DOCS) Dividend Will Be £0.0156
Jan 03Dr. Martens (LON:DOCS) Will Pay A Dividend Of £0.0156
Dec 13Dr. Martens (LON:DOCS) Is Very Good At Capital Allocation
Oct 12Calculating The Intrinsic Value Of Dr. Martens plc (LON:DOCS)
Sep 13Returns on Capital Paint A Bright Future For Dr. Martens (LON:DOCS)
Jul 12A Look At The Intrinsic Value Of Dr. Martens plc (LON:DOCS)
Jun 02Dr. Martens (LON:DOCS) Is Investing Its Capital With Increasing Efficiency
Feb 25Is There An Opportunity With Dr. Martens plc's (LON:DOCS) 34% Undervaluation?
Dec 17The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested
Oct 02Dr. Martens (LON:DOCS) Knows How To Allocate Capital Effectively
Jul 04Why Investors Shouldn't Be Surprised By Dr. Martens plc's (LON:DOCS) 26% Share Price Surge
Jun 16Are Investors Undervaluing Dr. Martens plc (LON:DOCS) By 27%?
Mar 02Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 19% Below Its Share Price
Dec 01Revenue & Expenses Breakdown
How Dr. Martens makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 877 | 69 | 378 | 0 |
| 31 Dec 23 | 927 | 86 | 386 | 0 |
| 30 Sep 23 | 978 | 103 | 395 | 0 |
| 30 Jun 23 | 989 | 116 | 384 | 0 |
| 31 Mar 23 | 1,000 | 129 | 373 | 0 |
| 31 Dec 22 | 979 | 153 | 372 | 0 |
| 30 Sep 22 | 957 | 177 | 371 | 0 |
| 30 Jun 22 | 933 | 179 | 343 | 0 |
| 31 Mar 22 | 908 | 181 | 316 | 0 |
| 31 Dec 21 | 867 | 118 | 310 | 0 |
| 30 Sep 21 | 825 | 54 | 304 | 0 |
| 30 Jun 21 | 799 | 44 | 276 | 0 |
| 31 Mar 21 | 773 | 35 | 248 | 0 |
| 31 Dec 20 | 747 | 61 | 219 | 0 |
| 30 Sep 20 | 722 | 87 | 191 | 0 |
| 30 Jun 20 | 697 | 81 | 204 | 0 |
| 31 Mar 20 | 672 | 75 | 217 | 0 |
| 31 Mar 19 | 454 | 17 | 124 | 0 |
| 31 Mar 18 | 349 | -6 | 94 | 0 |
| 31 Mar 17 | 291 | -11 | 75 | 0 |
| 31 Mar 16 | 232 | -12 | 56 | 0 |
| 31 Mar 15 | 235 | 0 | 50 | 0 |
| 31 Mar 14 | 164 | -32 | 24 | 0 |
Quality Earnings: DOCS has high quality earnings.
Growing Profit Margin: DOCS's current net profit margins (7.9%) are lower than last year (12.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: DOCS's earnings have grown by 17.6% per year over the past 5 years.
Accelerating Growth: DOCS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: DOCS had negative earnings growth (-46.3%) over the past year, making it difficult to compare to the Luxury industry average (2.7%).
Return on Equity
High ROE: DOCS's Return on Equity (18.8%) is considered low.